Clinical Trial Update: Trial of NanoPac® Focal Therapy in Subjects With Prostate Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial update for NanoPac focal therapy in prostate adenocarcinoma has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Adenocarcinoma of the Prostate
• Prostate Adenocarcinoma

Drugs mentioned

• NanoPac (paclitaxel nanoparticle formulation)

Snippet

Sponsor: NanOlogy, LLC | Conditions: Adenocarcinoma of the Prostate | Phase 2 | Status: COMPLETED | Results posted: 2019-08-20